Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: A literature review of randomized control trials

World Journal of Gastroenterology

Volumn 11, Issue 25, 2005, Pages 3817-3822

  Wang, Peng ^a,b   Chen, Zhen ^a,b   Huang, Wen Xia ^a,b   Liu, Lu Ming ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Hepatectomy; Metastatic colorectal cancer; Preventive treatment; Randomized control trials; Recurrence

Indexed keywords

DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; RECOMBINANT INTERLEUKIN 2;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; DRUG EFFICACY; DRUG INFUSION; DRUG TOLERABILITY; HEPATIC ARTERY; HUMAN; LEUKOCYTE TRANSFUSION; LIVER METASTASIS; LIVER RESECTION; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE;

EID: 22644434283     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i25.3817     Document Type: Article

References (36)

1. Liu LX, Zhang WH, Jiang HC. Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 2003; 9: 193-200
2. Cavallari A, Vivarelli M, Bellusci R, Montalti R, De Ruvo N, Cucchetti A, De Vivo A, De Raffele E, Salone M, La Barba G. Liver metastases from colorectal cancer: present surgical approach. Hepatogastroenterology 2003; 50: 2067-2071
3. Teh CS, Ooi LL. Hepatic resection for colorectal metastases to the liver: the national cancer centre/singapore general hospital experience. Ann Acad Med Singapore 2003; 32: 196-204
4. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318
5. Topal B, Kaufman L, Aerts R, Penninckx F. Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol 2003; 29: 248-253
6. Nakajima Y, Nagao M, Ko S, Kanehiro H, Hisanaga M, Aomatsu Y, Ikeda N, Shibaji T, Ogawa S, Nakano H. Clinical predictors of recurrence site after hepatectomy for metastatic colorectal cancer. Hepatogastroenterology 2001; 48: 1680-1684
7. Rustum YM, Harstrick A, Cao S, Vanhoefer U, Yin MB, Wilke H, Seeber S. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J Clin Oncol 1997; 15: 389-400
8. Lygidakis NJ, Ziras N, Parissis J. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 1995; 42: 155-161
9. Asahara T, Kikkawa M, Okajima M, Ojima Y, Toyota K, Nakahara H, Katayama K, Itamoto T, Marubayashi S, One E, Yahata H, Dohi K, Azuma K, Ito K. Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy. Hepatogastroenterology 1998; 45: 805-811
10. Rudroff C, Altendorf-Hoffmann A, Stangl R, Scheele J. Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbecks Arch Surg 1999; 384: 243-249
11. Lorenz M, Muller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K, Hauss J, Stieger R, Jauch KW, Bechstein WO, Encke A. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 1998; 228: 756-762
12. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039-2048
13. Tono T, Hasuike Y, Ohzato H, Takatsuka Y, Kikkawa N. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study. Cancer 2000; 88: 1549-1556
14. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, Sigurdson ER, O'Dwyer PJ, Benson AB 3rd. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol 2002; 20: 1499-1505
15. Nelson RL, Freels S. A systematic review of hepatic artery chemotherapy after hepatic resection of colorectal cancer metastatic to the liver. Dis Colon Rectum 2004; 47: 739-745
16. Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L, Rougier P. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355: 1041-1047
17. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000; 343: 905-914
18. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-2947
19. Tournigand C, Louvet C, Quinaux E, Andre T, Lledo G, Flesch M, Ganem G, Landi B, Colin P, Denet C, Mery-Mignard D, Risse ML, Buyse M, de Gramont A. FOLFIRI Followed by FOLFOX Versus FOLFOX Followed by FOLFIRI in Metastatic Colorectal Cancer (MCRC): Final Results of a Phase III Study. Proc Am Soc Clin Oncol 2001; abstr494. Available from: URL: http://www.asco.org/ac/1,1003,_12-002643-00_18-0010-00_19-00494,00.asp
20. Jarnagin WR, Gonen M, Blumgart L, Sperber D, Koenigsberg A, Fong Y, Kemeny N. Completed phase I trial of hepatic arterial infusion with floxuridine and dexamethasone in combination with systemic irinotecan after resection of hepatic metastases from colorectal cancer. Proc Am Soc Clin Oncol 2003; abstr 1073. Available from: URL: http://www.asco.org/ac/1,1003,_12-002643-00_18-0023-00_19-00100969,00.asp
21. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002; 38: 1023-1033
22. Yap B, Sheen A, Eaton D, Swindell R, James R, Levine E, Valle J, Hawkins R, Sherlock D, Saunders M. A large single centre cohort of adjuvant chemotherapy following curative resection of hepatic colorectal metastases. Proc Am Soc Clin Oncol 2002; abstr 2367. Available from: URL: http://www.asco.org/ac/1,1003,_12-002643-00_18-0016-00_19-002367,00.asp
23. Portier G, Rougier P, Milan C, Bouché O, Gillet M, Bosset JF, Ducreux M, Saric J, Bugat R, Stremsdoerfer N, Nordlinger B, Bedenne L, Lazorthes F. Adjuvant systemic chemotherapy (CT) using 5-fluorouracil (FU) and folinic acid (FA) after resection of liver metastases (LM) from colorectal (CRC) origin. Results of an intergroup phase III study (trial FFCD - ACHBTH - AURC 9002). Proc Am Soc Clin Oncol 2002; abstr 528. Available from: URL:http://www.asco.org/ac/1,1003,_12-002643-00_18-0016-00_19- 00528,00.asp
24. Lopez-Ladron A, Salvador J, Bernabe R, Bernardos A, Arriola E, Serrano J, Reina JJ, Gomez MA, Barneto I, Moreno-Nogueira JA. Observation versus postoperative chemotherapy after resection of liver metastases in patients with advanced colorectal cancer. Proc Am Soc Clin Oncol 2003 abstr 1497. Available from: URL:http://www.asco.org/ac/1,1003,_12-002643-00_18-0023-00_19- 00104357,00.asp
25. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509-520
26. Meric F, Patt YZ, Curley SA, Chase J, Roh MS, Vauthey JN, Ellis LM. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 2000; 7: 490-495
27. Adam R, Huguet E, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth H. Hepatic resection after down-staging of unresectable hepatic colorectal metastases. Surg Oncol Clin N Am 2003; 12: 211-220
28. Clavien PA, Selzner N, Morse M, Selzner M, Paulson E. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery 2002; 131: 433-442
29. Lorenz M, Staib-Sebler E, Gog C, Proschek D, Jauch KW, Ridwelski K, Hohenberger W, Gassel HJ, Lehmann U, Vestweber KH, Padberg W, Zamzow K, Muller HH. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies. Zentralbl Chir 2003; 128: 87-94
30. Bathe OF, Dowden S, Sutherland F, Dixon E, Butts C, Bigam D, Walley B, Ruether D, Ernst S. Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma. BMC Cancer 2004; 4: 32
31. Hanna MG Jr, Hoover HC Jr, Vermorken JB, Harris JE, Pinedo HM. Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise. Vaccine 2001; 19: 2576-2582
32. Huncharek M, Caubet JF, McGarry R. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials. Melanoma Res 2001; 11: 75-81
33. Lygidakis NJ, Stringaris K, Kokinis K, Lyberopoulos K, Raptis S. Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study. Hepatogastroenterology 1996; 43: 212-220
34. Lygidakis NJ, Sgourakis G, Vlachos L, Raptis S, Safioleas M, Boura P, Kountouras J, Alamani M. Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study. Hepatogastroenterology 2001; 48: 1685-1691
35. Elias D, Farace F, Triebel F, Hattchouel JM, Pignon JP, Lecesne A, Rougier P, Lasser P, Duvillard P, Escudier B. Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectum. J Am Coll Surg 1995; 181: 303-310
36. Gardini A, Ercolani G, Riccobon A, Ravaioli M, Ridolfi L, Flamini E, Ridolfi R, Grazi GL, Cavallari A, Amadori D. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. J Surg Oncol 2004; 87: 46-52